Diagnosis

AI tool detects heart failure from a single heartbeat

Researchers develop a neural diagnostic tool which can detect cardiac anomalies with 100% accuracy Artificial intelligence (AI) has now taken another step forward in healthcare,...

Boris allocates £250m to NHS for AI

Pledge to use artificial intelligence to speed up diagnosis - but can the NHS keep-pace with AI recruitment costs? In its third pledge to the...

FDA approves Qclarity as first ever breast-cancer diagnostic AI

Qclarity, produced by Paragon Biosciences, looks to improve the quality and speed of breast cancer diagnoses. About 30 million women are screened for breast cancer...

Amprion’s test a game-changer for Parkinson’s

FDA grants “Breakthrough Device” designation to Amprion's new technology as it is fast-tracked to market. Parkinson's is a debilitating chronic, progressive neurodegenerative disease that is...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.